跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GAVISCON PEPPERMINT TABLETS - HSA Drug Approval Details
Approvals
/
HSA
/
GAVISCON PEPPERMINT TABLETS
Approved
THERAPEUTIC
GAVISCON PEPPERMINT TABLETS
RECKITT BENCKISER HEALTHCARE (UK) LIMITED (UNITED KINGDOM)
🇸🇬 Health Sciences Authority
Approval Date
Apr 14, 2011
Approval ID
2dc2f00950737bb0
Company
RECKITT BENCKISER HEALTHCARE (UK) LIMITED (UNITED KINGDOM)
Type
Therapeutic
Approval Details
Approval Id
2dc2f00950737bb0
Drug Name
GAVISCON PEPPERMINT TABLETS
Product Name
GAVISCON PEPPERMINT TABLETS
Approval Number
SIN13947P
Approval Date
2011-04-14
Registrant
RECKITT BENCKISER (SINGAPORE) PTE LTD
Licence Holder
RECKITT BENCKISER (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
A02BX13
Atc Item Name
alginic acid
Pharma Manufacturer Name
RECKITT BENCKISER (SINGAPORE) PTE LTD
Active Ingredients
CALCIUM CARBONATE
80MG
SODIUM BICARBONATE
133.5MG
SODIUM ALGINATE
250MG
CALCIUM CARBONATE
80 MG
SODIUM ALGINATE
250 MG
SODIUM BICARBONATE
133.5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 14, 2011
Approval ID
2dc2f00950737bb0
Type
Therapeutic
Back to HSA Approvals